课题基金 / 基金详情

NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)

NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
NIH 四聚体核心设施(艾滋病毒/艾滋病以外的传染病)
批准号:
10376128
负责人:
JOHN ALTMAN
金额:
$200.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-21 至 2027-03-20

项目摘要

项目成果

JOHN ALTMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The National Institute of Allergy and Infectious Diseases (NIAID) supports research on the basic understanding of immune responses leading to the development of vaccines and novel therapeutic agents for the prevention and treatment of infectious and immune-mediated diseases, and improvements in public health. This research includes support of various reagent facilities, repositories, and databases that provide resources for biomedical researchers. As a part of the research program to improve our understanding of the progression, prevention, and treatment of infectious and immune-mediated diseases, the NIAID supports the NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility. This facility provides synthesis and distribution of soluble MHC tetramer reagents to the global research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task Order B-5_75N93022F00002; 09/19/2022-03/20/2023; $18,543.00.
  • 批准号:
    10703781
  • 项目类别:
  • 资助金额:
    $1.85万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
NIH TETRAMER CORE FACILITY (HIV/AIDS)
  • 批准号:
    10376127
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
NIH Tetramer Core Facility
  • 批准号:
    10812213
  • 项目类别:
  • 资助金额:
    $148.79万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
Tetramer Research & Development Contract (Influenza)
  • 批准号:
    10678192
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
海外基金